Ikarian Capital as of Dec. 31, 2019
Portfolio Holdings for Ikarian Capital
Ikarian Capital holds 91 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Intercept Pharmaceuticals In | 16.5 | $102M | 820k | 123.91 | |
Intra Cellular Therapies (ITCI) | 6.6 | $41M | 1.2M | 34.31 | |
SPDR S&P Biotech (XBI) | 5.4 | $33M | 350k | 95.11 | |
Gilead Sciences (GILD) | 5.3 | $33M | 500k | 64.98 | |
iShares NASDAQ Biotechnology Index (IBB) | 4.9 | $30M | 250k | 120.51 | |
ArQule | 3.2 | $20M | 983k | 19.96 | |
Mirati Therapeutics (MRTX) | 3.1 | $19M | 149k | 128.85 | |
Apellis Pharmaceuticals (APLS) | 2.6 | $16M | 527k | 30.62 | |
Allakos (ALLK) | 2.5 | $15M | 159k | 95.36 | |
Sarepta Therapeutics (SRPT) | 2.1 | $13M | 103k | 129.04 | |
Madrigal Pharmaceuticals (MDGL) | 2.1 | $13M | 145k | 91.11 | |
Beigene (BGNE) | 2.1 | $13M | 77k | 165.77 | |
Arrowhead Pharmaceuticals (ARWR) | 2.1 | $13M | 200k | 63.43 | |
Gossamer Bio (GOSS) | 1.9 | $12M | 771k | 15.63 | |
Biohaven Pharmaceutical Holding | 1.8 | $11M | 201k | 54.52 | |
Gw Pharmaceuticals Plc ads | 1.7 | $11M | 100k | 104.56 | |
Aurinia Pharmaceuticals (AUPH) | 1.6 | $9.7M | 481k | 20.26 | |
Sage Therapeutics (SAGE) | 1.6 | $9.6M | 133k | 72.19 | |
Ascendis Pharma A S (ASND) | 1.6 | $9.7M | 69k | 139.12 | |
Immunomedics | 1.5 | $9.5M | 448k | 21.16 | |
Immunovant (IMVT) | 1.3 | $8.0M | 504k | 15.87 | |
Zogenix | 1.3 | $8.0M | 153k | 52.17 | |
Global Blood Therapeutics In | 1.3 | $7.9M | 100k | 79.49 | |
Crispr Therapeutics (CRSP) | 1.2 | $7.5M | 124k | 60.91 | |
Incyte Corporation (INCY) | 1.1 | $7.0M | 80k | 87.32 | |
Assembly Biosciences (ASMB) | 1.0 | $6.3M | 308k | 20.46 | |
Deciphera Pharmaceuticals (DCPH) | 1.0 | $6.2M | 100k | 62.24 | |
ACADIA Pharmaceuticals (ACAD) | 1.0 | $6.0M | 140k | 42.78 | |
Aptose Biosciences | 0.9 | $5.7M | 1.0M | 5.67 | |
Eidos Therapeutics | 0.9 | $5.7M | 100k | 57.39 | |
Chiasma | 0.9 | $5.5M | 1.1M | 4.96 | |
Anaptysbio Inc Common (ANAB) | 0.9 | $5.5M | 336k | 16.25 | |
Clovis Oncology | 0.9 | $5.4M | 514k | 10.42 | |
Kala Pharmaceuticals | 0.8 | $5.2M | 1.4M | 3.69 | |
Ardelyx (ARDX) | 0.8 | $4.8M | 645k | 7.51 | |
Amarin Corporation (AMRN) | 0.8 | $4.7M | 218k | 21.44 | |
Adverum Biotechnologies (ADVM) | 0.7 | $4.5M | 391k | 11.52 | |
Myokardia | 0.7 | $4.3M | 59k | 72.88 | |
Otonomy | 0.7 | $4.1M | 1.1M | 3.83 | |
Puma Biotechnology (PBYI) | 0.6 | $3.9M | 444k | 8.75 | |
Karyopharm Therapeutics (KPTI) | 0.6 | $3.8M | 200k | 19.17 | |
Kalvista Pharmaceuticals (KALV) | 0.6 | $3.8M | 212k | 17.81 | |
Tg Therapeutics (TGTX) | 0.6 | $3.5M | 316k | 11.10 | |
Wave Life Sciences (WVE) | 0.6 | $3.5M | 434k | 8.01 | |
Viking Therapeutics (VKTX) | 0.6 | $3.4M | 426k | 8.02 | |
Xenon Pharmaceuticals (XENE) | 0.5 | $3.2M | 244k | 13.11 | |
Axsome Therapeutics (AXSM) | 0.5 | $2.9M | 28k | 103.37 | |
Ocular Therapeutix (OCUL) | 0.5 | $2.8M | 708k | 3.95 | |
Cerecor | 0.5 | $2.8M | 520k | 5.39 | |
Cel Sci (CVM) | 0.5 | $2.7M | 300k | 9.15 | |
Agios Pharmaceuticals (AGIO) | 0.4 | $2.4M | 50k | 47.76 | |
Bioxcel Therapeutics (BTAI) | 0.4 | $2.3M | 158k | 14.61 | |
Ultragenyx Pharmaceutical (RARE) | 0.3 | $2.1M | 50k | 42.72 | |
Aduro Biotech | 0.3 | $2.2M | 1.8M | 1.18 | |
Chemocentryx | 0.3 | $1.8M | 46k | 39.55 | |
Mallinckrodt Pub | 0.3 | $1.8M | 512k | 3.49 | |
Macrogenics (MGNX) | 0.3 | $1.7M | 160k | 10.87 | |
Coherus Biosciences (CHRS) | 0.2 | $1.5M | 84k | 18.00 | |
Insmed (INSM) | 0.2 | $1.5M | 61k | 23.87 | |
Ovid Therapeutics (OVID) | 0.2 | $1.5M | 350k | 4.15 | |
Inflarx Nv (IFRX) | 0.2 | $1.4M | 359k | 3.96 | |
Aimmune Therapeutics | 0.2 | $1.3M | 40k | 33.48 | |
Solid Biosciences | 0.2 | $1.4M | 306k | 4.45 | |
Mustang Bio | 0.2 | $1.3M | 323k | 4.08 | |
Minerva Neurosciences | 0.2 | $1.2M | 175k | 7.11 | |
Precision Biosciences Ord (DTIL) | 0.2 | $1.1M | 80k | 13.89 | |
Axovant Gene The | 0.2 | $967k | 189k | 5.12 | |
Applied Genetic Technol Corp C | 0.1 | $908k | 201k | 4.52 | |
Neurocrine Biosciences (NBIX) | 0.1 | $774k | 7.2k | 107.50 | |
Dbv Technologies S A (DBVT) | 0.1 | $798k | 75k | 10.71 | |
Rigel Pharmaceuticals (RIGL) | 0.1 | $749k | 350k | 2.14 | |
Progenics Pharmaceuticals | 0.1 | $666k | 131k | 5.09 | |
Bellus Health | 0.1 | $625k | 64k | 9.81 | |
Protagonist Therapeutics (PTGX) | 0.1 | $552k | 78k | 7.05 | |
Molecular Templates | 0.1 | $572k | 41k | 13.98 | |
Prothena (PRTA) | 0.1 | $472k | 30k | 15.82 | |
Chimerix (CMRX) | 0.1 | $351k | 173k | 2.03 | |
Cara Therapeutics (CARA) | 0.1 | $353k | 22k | 16.10 | |
Dicerna Pharmaceuticals | 0.1 | $341k | 16k | 22.00 | |
Obseva Sa | 0.1 | $315k | 83k | 3.81 | |
Arvinas Ord (ARVN) | 0.0 | $254k | 6.2k | 40.97 | |
Proteon Therapeutics | 0.0 | $138k | 336k | 0.41 | |
Aeterna Zentaris | 0.0 | $107k | 117k | 0.91 | |
Sierra Oncology | 0.0 | $131k | 386k | 0.34 | |
Magenta Therapeutics | 0.0 | $131k | 8.7k | 15.10 | |
X4 Pharmaceuticals (XFOR) | 0.0 | $107k | 10k | 10.70 | |
Stealth Biotherapeutics Corp | 0.0 | $123k | 38k | 3.27 | |
Novavax (NVAX) | 0.0 | $100k | 25k | 3.99 | |
Pieris Pharmaceuticals (PIRS) | 0.0 | $80k | 22k | 3.64 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $38k | 111k | 0.34 | |
Alpine Immune Sciences (ALPN) | 0.0 | $18k | 4.7k | 3.80 |